.jpg)
Euronext, the leading exchange in the Eurozone, today announces the results of the annual review of the AEX®, AMX® and AScX® indices. The changes due to the review will be effective from Monday 20 March 2017.
AEX®
No changes.
AMX®
No changes.
AScX®
|
INCLUSION OF: |
EXCLUSION OF: |
|---|---|
|
Hunter Douglas |
Kiadis Pharma |
The compiler retains the right to change the published selection, for instance in case of a removal due to a take-over, till the publication of the final data after close of Wednesday 15 March 2017. All events happening after that date will not lead to a replacement of the selected company that possibly needs to be removed from the final selection.
Review AEX family
The AEX family is reviewed quarterly in June, September and December. The full annual review is in March. The quarterly reviews serve to replace removed constituents and to facilitate inclusion of recently listed companies.
